Get started
ALTIMMUNE, INCALTIMMUNE, INCALTIMMUNE, INC

ALTIMMUNE, INC

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals

ALT1 chart


Full chart

ALT1 upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.41 B‬ MXN
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−27.91 MXN
Net income (FY)
‪−1.98 B‬ MXN
Revenue (FY)
‪416.99 K‬ MXN
Shares float
‪76.21 M‬
Beta (1Y)
2.29

Employees


Employees (FY)
59
Change (1Y)
0
Revenue / Employee (1Y)
‪7.07 K‬ MXN
Net income / Employee (1Y)
‪−33.59 M‬ MXN

About Altimmune, Inc.


Sector
Health Technology
Industry
Biotechnology
CEO
Vipin K. Garg
Website
altimmune.com
Headquarters
Gaithersburg
Founded
1997
FIGI
BBG00Z6DKR14
Altimmune, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of novel peptide-based therapeutics for the treatment of obesity and liver diseases. The company's lead product candidate, pemvidutide, is a GLP-1/glucagon dual receptor agonist that is being developed for the treatment of obesity and NASH. In addition, Altimmune is developing HepTcell, an immunotherapeutic designed to achieve a functional cure for chronic hepatitis B. The company was founded in 1997 and is headquartered in Gaithersburg, MD.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

ALT1 news



Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Check out other big names from the same industry as ALT1.

Frequently Asked Questions


The current price of ALT1 is 99.57 MXN — it has decreased by −0.43% in the past 24 hours. Watch ALTIMMUNE, INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BIVA exchange ALTIMMUNE, INC stocks are traded under the ticker ALT1.
ALT1 stock has fallen by −1.65% compared to the previous week, the month change is a −15.60% fall, over the last year ALTIMMUNE, INC has showed a −39.57% decrease.
We've gathered analysts' opinions on ALTIMMUNE, INC future price: according to them, ALT1 price has a max estimate of 574.70 MXN and a min estimate of 246.30 MXN. Watch ALT1 chart and read a more detailed ALTIMMUNE, INC stock forecast: see what analysts think of ALTIMMUNE, INC and suggest that you do with its stocks.
ALT1 stock is 0.43% volatile and has beta coefficient of 2.29. Track ALTIMMUNE, INC stock price on the chart and check out the list of the most volatile stocks — is ALTIMMUNE, INC there?
Today ALTIMMUNE, INC has the market capitalization of ‪8.41 B‬, it has increased by 2.30% over the last week.
Yes, you can track ALTIMMUNE, INC financials in yearly and quarterly reports right on TradingView.
ALTIMMUNE, INC is going to release the next earnings report on May 13, 2025. Keep track of upcoming events with our Earnings Calendar.
ALT1 earnings for the last quarter are −6.88 MXN per share, whereas the estimation was −6.93 MXN resulting in a 0.75% surprise. The estimated earnings for the next quarter are −7.21 MXN per share. See more details about ALTIMMUNE, INC earnings.
ALTIMMUNE, INC revenue for the last quarter amounts to ‪104.25 K‬ MXN, matching the estimated figure, and no changes in revenue are expected for the next quarter.
ALT1 net income for the last quarter is ‪−483.29 M‬ MXN, while the quarter before that showed ‪−450.13 M‬ MXN of net income which accounts for −7.37% change. Track more ALTIMMUNE, INC financial stats to get the full picture.
No, ALT1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 11, 2025, the company has 59 employees. See our rating of the largest employees — is ALTIMMUNE, INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ALTIMMUNE, INC EBITDA is ‪−2.15 B‬ MXN, and current EBITDA margin is ‪−514.67 K‬%. See more stats in ALTIMMUNE, INC financial statements.
Like other stocks, ALT1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ALTIMMUNE, INC stock right from TradingView charts — choose your broker and connect to your account.